EV/EBITDA
-13.95
-0.09-0.65%
12 min ago
Summary:
Theravance Biopharma EV/EBITDA is currently -13.95, with a fall of -0.09 (-0.65%) during the most recent trading day. TBPH EV/EBITDA is now -956.82% below its all-time high of -1.32.TBPH EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -0.7% |
| 1 m1 month | +4.9% |
| 6 m6 months | - |
| ytdytd | +0.4% |
| 1 y1 year | - |
| 5 y5 years | -56.7% |
TBPH EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -13.82 | -0.9% | -14.95 | +6.7% |
| 3 m | 3 months | -13.76 | -1.4% | -14.95 | +6.7% |
| 6 m | 6 months | -11.73 | -18.9% | -14.95 | +6.7% |
| 1 y | 1 year | -11.73 | -18.9% | -14.95 | +6.7% |
| 3 y | 3 years | -2.32 | -501.3% | -14.95 | +6.7% |
| 5 y | 5 years | -2.32 | -501.3% | -14.95 | +6.7% |
| alltime | all time | -1.32 | -956.8% | -14.95 | +6.7% |
Theravance Biopharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.95(-0.4%) |
| 2024 | -14.00(+134.9%) |
| 2022 | -5.96(-11.0%) |
| 2021 | -6.70(+10.9%) |
| 2020 | -6.04(-36.2%) |
| Date | Value |
|---|---|
| 2019 | -9.47(+33.9%) |
| 2018 | -7.07(+11.0%) |
| 2017 | -6.37(-28.2%) |
| 2016 | -8.87(+210.1%) |
| 2015 | -2.86(+66.3%) |
| 2014 | -1.72 |
FAQ
- What is Theravance Biopharma EV/EBITDA?
- What is the all time high EV/EBITDA for Theravance Biopharma?
- What is TBPH EV/EBITDA year-to-date change?
What is Theravance Biopharma EV/EBITDA?
The current EV/EBITDA of TBPH is -13.95
What is the all time high EV/EBITDA for Theravance Biopharma?
Theravance Biopharma all-time high EV/EBITDA is -1.32
What is TBPH EV/EBITDA year-to-date change?
Theravance Biopharma EV/EBITDA has changed by +0.05 (+0.36%) since the beginning of the year